Orange Book product · Generic (ANDA)
DOXERCALCIFEROL
DOXERCALCIFEROL
At a glance
Sep 15, 2020
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 15, 2020
5 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
DOXERCALCIFEROL
Strength
0.5MCG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 205360
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DOXERCALCIFEROL
- 2018DOXERCALCIFEROLBrand (NDA)
NDA 208614 · HOSPIRA
- 2004HECTOROLBrand (NDA)
NDA 020862 · SANOFI
- 2000HECTOROLBrand (NDA)
NDA 021027 · SANOFI
- 2023DOXERCALCIFEROLGeneric (ANDA)
ANDA 215810 · ALEMBIC
- 2022DOXERCALCIFEROLGeneric (ANDA)
ANDA 213717 · EUGIA PHARMA
- 2020DOXERCALCIFEROLGeneric (ANDA)
ANDA 211670 · MEITHEAL
- 2019DOXERCALCIFEROLGeneric (ANDA)
ANDA 203875 · SUN PHARM
- 2019DOXERCALCIFEROLGeneric (ANDA)
ANDA 210452 · GLAND
- 2018DOXERCALCIFEROLGeneric (ANDA)
ANDA 210801 · LUPIN
- 2017DOXERCALCIFEROLGeneric (ANDA)
ANDA 208974 · AMNEAL
- 2017DOXERCALCIFEROLGeneric (ANDA)
ANDA 208975 · AMNEAL
- 2016DOXERCALCIFEROLGeneric (ANDA)
ANDA 201518 · RISING
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
